The president announced that Gilead had been granted the emergency use authorization and is enthusiastic about the drug.
It is able to interfere with the virus's genome and can disrupt its ability to replicate.
"The limited preclinical data on remdesivir in MERS and SARS indicate that remdesivir may have potential activity against COVID-19," the company said, describing it as"an experimental medicine that does not have established safety or efficacy for the treatment of any condition."CDC recommends wearing a cloth face covering in public where social distancing measures are difficult to maintain.
Practice safe removal of face coverings by not touching eyes, nose, and mouth, and wash hands immediately after removing the covering.Clean hands frequently with soap and water, or alcohol-based hand rub. Cover your mouth and nose with a tissue or bent elbow when coughing or sneezing. Discard the tissue immediately and clean your hands.Stay at home if you feel unwell, even with mild symptoms such as headache and runny nose, to avoid potential spread of the disease to medical facilities and other people.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
U.S. FDA moving with 'lightning speed' on Gilead's COVID-19 drug: BloombergThe U.S. Food and Drug Administration is working at 'lightning speed' to review data on Gilead Sciences Inc's experimental antiviral drug remdesivir in treating COVID-19 disease, the head of the agency told Bloomberg in an interview.
Read more »
FDA clears remdesivir for emergency use in treating severely ill COVID-19 patientsBREAKING: FDA authorizes emergency use of remdesivir to treat the most severely ill coronavirus patients.
Read more »
FDA authorizes remdesivir drug as emergency treatment for COVID-19The U.S. Food and Drug Administration (FDA) has granted authorization to Gilead Sciences Inc for emergency use of its experimental antiviral drug remdesivir to treat patients with COVID-19, it said in a letter to Gilead.
Read more »
FDA Authorizes Emergency Use of Gilead Drug Remdesivir for Covid-19 PatientsThe Food and Drug Administration’s move came after researchers reported that the Gilead drug shortened the recovery times in people who have fallen ill from the new coronavirus.
Read more »
FDA Has Approved Emergency Use Of Remdesivir To Treat COVID-19The approval comes days after the NIH announcement of preliminary results showing a four-day shortening of hospital stays after treatment with the drug.
Read more »
FDA Gives Emergency Authorization For Some COVID-19 Patients To Use RemdesivirThe FDA has given emergency use authorization to remdesivir to treat hospitalized COVID-19 patients, President Trump said. The news comes days after preliminary results from a study of the drug showed it can help patients recover faster.
Read more »